Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Anat ; 184(1): 27-34, 2002 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11876479

RESUMO

The great variation of primary cheiloplasty procedures in Cleft Lip and Palate (CLP) patients shows that there is disagreement regarding the embryonic development of this part of the face, the macroscopic and microscopic functional anatomy of the human muscles of facial expression and their role as a functional matrix for balanced and harmonious facial development. The purpose of this study is to present results of microsurgically dissected facial muscles, several parts of the nose and the human midface in specimens with and without cleft lip and palate. The results are compared with those of other investigations. Recommendations are presented for a standardized dissection technique of the facial muscles of expression for different types of primary cheilo- and rhinoplasty techniques.


Assuntos
Fenda Labial/patologia , Fenda Labial/cirurgia , Fissura Palatina/patologia , Fissura Palatina/cirurgia , Expressão Facial , Músculos Faciais/anatomia & histologia , Fácies , Procedimentos de Cirurgia Plástica , Rinoplastia , Músculos Faciais/patologia , Músculos Faciais/cirurgia , Feminino , Humanos , Recém-Nascido , Masculino , Microcirurgia , Valores de Referência
2.
Can J Neurol Sci ; 17(1): 78-82, 1990 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2107017

RESUMO

Growth hormone (GH) serum levels in response to the administration of aminergic drugs and thyroliberine (TRH) were determined in a group of 34 acromegalics. Administration of bromocriptine (10 mg single oral dose) was followed by a decrease in GH below 60% control values in 35% of the cases. Administration of diazepam (10 mg single oral dose) to those cases not responding to bromocriptine induced a decrease in GH in 58% of the cases and an increase in GH in 42%. Administration of cyproheptadine (24 mg/day for one month) to those cases not responding to bromocriptine or with increased GH after the administration of diazepam, decreased GH in 75%, while increased GH in 25% of the cases. TRH 200 micrograms single I.V. dose induced increase of 128% GH basal level in 65% of cases (TRH positive) which correlated with more benign clinical course, decreased GH levels in response to bromocriptine, increased PRL levels, PRL-GH mixed secreting adenomas in immunohistochemistry studies, presence of granulated cells in electron microscopy studies and normalization of GH in the majority of surgically treated cases. By contrast, TRH negative cells correlated with aggressive tumor growth, lack of response to bromocriptine, normal PRL levels, pure GH secreting adenomas by immunohistochemistry, poorly granulated cells and lack of response to surgical treatment. Results suggest that there is more than one type of acromegaly that might be distinguished by the aminergic control on GH secretion.


Assuntos
Acromegalia/fisiopatologia , Adenoma/metabolismo , Bromocriptina/uso terapêutico , Ciproeptadina/uso terapêutico , Diazepam/uso terapêutico , Hormônio do Crescimento/metabolismo , Neoplasias Hipofisárias/metabolismo , Hormônio Liberador de Tireotropina/farmacologia , Acromegalia/sangue , Acromegalia/tratamento farmacológico , Adenoma/sangue , Adenoma/tratamento farmacológico , Adenoma/ultraestrutura , Adolescente , Adulto , Feminino , Hormônio do Crescimento/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Hipofisárias/sangue , Neoplasias Hipofisárias/tratamento farmacológico , Neoplasias Hipofisárias/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...